368 related articles for article (PubMed ID: 9112024)
1. Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.
Müller C; Assimacopoulos-Jeannet F; Mosimann F; Schneiter P; Riou JP; Pachiaudi C; Felber JP; Jéquier E; Jeanrenaud B; Tappy L
Diabetologia; 1997 Apr; 40(4):463-8. PubMed ID: 9112024
[TBL] [Abstract][Full Text] [Related]
2. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
[TBL] [Abstract][Full Text] [Related]
3. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
5. Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects.
Paquot N; Schneiter P; Jéquier E; Gaillard R; Lefèbvre PJ; Scheen A; Tappy L
Diabetologia; 1996 May; 39(5):580-6. PubMed ID: 8739918
[TBL] [Abstract][Full Text] [Related]
6. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
Wise S; Nielsen M; Rizza R
J Clin Endocrinol Metab; 1997 Jun; 82(6):1828-33. PubMed ID: 9177391
[TBL] [Abstract][Full Text] [Related]
7. Lipid-dependent control of hepatic glycogen stores in healthy humans.
Stingl H; Krssák M; Krebs M; Bischof MG; Nowotny P; Fürnsinn C; Shulman GI; Waldhäusl W; Roden M
Diabetologia; 2001 Jan; 44(1):48-54. PubMed ID: 11206411
[TBL] [Abstract][Full Text] [Related]
8. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
[TBL] [Abstract][Full Text] [Related]
9. The actions of dichloroacetic acid on blood glucose, liver glycogen and fatty acid synthesis in obese-hyperglycaemic (ob/ob) and lean mice.
Enser M; Whittington FM
Horm Metab Res; 1983 May; 15(5):225-9. PubMed ID: 6347856
[TBL] [Abstract][Full Text] [Related]
10. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
[TBL] [Abstract][Full Text] [Related]
11. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
[TBL] [Abstract][Full Text] [Related]
12. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats.
Fujimoto Y; Torres TP; Donahue EP; Shiota M
Diabetes; 2006 Sep; 55(9):2479-90. PubMed ID: 16936196
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM.
Diraison F; Large V; Brunengraber H; Beylot M
Diabetologia; 1998 Feb; 41(2):212-20. PubMed ID: 9498656
[TBL] [Abstract][Full Text] [Related]
14. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.
Clore JN; Post EP; Bailey DJ; Nestler JE; Blackard WG
J Clin Endocrinol Metab; 1992 Mar; 74(3):660-6. PubMed ID: 1740502
[TBL] [Abstract][Full Text] [Related]
15. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
16. A non-invasive assessment of hepatic glycogen kinetics and post-absorptive gluconeogenesis in man.
Gay LJ; Schneiter P; Schutz Y; Di Vetta V; Jéquier E; Tappy L
Diabetologia; 1994 May; 37(5):517-23. PubMed ID: 8056191
[TBL] [Abstract][Full Text] [Related]
17. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P
J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277
[TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic glucose production in healthy subjects and patients with non-insulin-dependent diabetes mellitus.
Tappy L
Diabete Metab; 1995 Oct; 21(4):233-40. PubMed ID: 8529757
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
[TBL] [Abstract][Full Text] [Related]
20. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
